EYPT
Price
$12.12
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
One day until earnings call
ORMP
Price
$2.32
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
10 days until earnings call
Ad is loading...

EYPT vs ORMP

Header iconEYPT vs ORMP Comparison
Open Charts EYPT vs ORMPBanner chart's image
EyePoint Pharmaceuticals
Price$12.12
Change-$0.00 (-0.00%)
Volume$4.57M
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.32
Change-$0.00 (-0.00%)
Volume$177.04K
CapitalizationN/A
View a ticker or compare two or three
EYPT vs ORMP Comparison Chart
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
EYPT vs. ORMP commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Buy and ORMP is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (EYPT: $12.12 vs. ORMP: $2.32)
Brand notoriety: EYPT and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 721% vs. ORMP: 194%
Market capitalization -- EYPT: $427.08M vs. ORMP: $99.48M
EYPT [@Biotechnology] is valued at $427.08M. ORMP’s [@Biotechnology] market capitalization is $99.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, EYPT is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • EYPT’s TA Score: 5 bullish, 4 bearish.
  • ORMP’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than ORMP.

Price Growth

EYPT (@Biotechnology) experienced а +13.27% price change this week, while ORMP (@Biotechnology) price change was -1.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

EYPT is expected to report earnings on Feb 27, 2025.

ORMP is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($427M) has a higher market cap than ORMP($99.5M). ORMP YTD gains are higher at: 0.433 vs. EYPT (-47.555). ORMP has higher annual earnings (EBITDA): 25.5M vs. EYPT (-85.85M). EYPT has more cash in the bank: 280M vs. ORMP (153M). ORMP has less debt than EYPT: ORMP (486K) vs EYPT (23.3M). EYPT has higher revenues than ORMP: EYPT (50.4M) vs ORMP (0).
EYPTORMPEYPT / ORMP
Capitalization427M99.5M429%
EBITDA-85.85M25.5M-337%
Gain YTD-47.5550.433-10,985%
P/E RatioN/A4.78-
Revenue50.4M0-
Total Cash280M153M183%
Total Debt23.3M486K4,794%
FUNDAMENTALS RATINGS
EYPT vs ORMP: Fundamental Ratings
EYPT
ORMP
OUTLOOK RATING
1..100
826
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9754
PRICE GROWTH RATING
1..100
5056
P/E GROWTH RATING
1..100
3099
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (53) in the Pharmaceuticals Other industry is in the same range as EYPT (61) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew similarly to EYPT’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as EYPT (100) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew similarly to EYPT’s over the last 12 months.

ORMP's SMR Rating (54) in the Pharmaceuticals Other industry is somewhat better than the same rating for EYPT (97) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew somewhat faster than EYPT’s over the last 12 months.

EYPT's Price Growth Rating (50) in the Pharmaceuticals Major industry is in the same range as ORMP (56) in the Pharmaceuticals Other industry. This means that EYPT’s stock grew similarly to ORMP’s over the last 12 months.

EYPT's P/E Growth Rating (30) in the Pharmaceuticals Major industry is significantly better than the same rating for ORMP (99) in the Pharmaceuticals Other industry. This means that EYPT’s stock grew significantly faster than ORMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EYPTORMP
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with ATHE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then ATHE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+27.58%
ATHE - EYPT
52%
Loosely correlated
-0.86%
OCUL - EYPT
50%
Loosely correlated
+2.06%
LYRA - EYPT
39%
Loosely correlated
+1.36%
GLYC - EYPT
36%
Loosely correlated
-2.77%
ORMP - EYPT
35%
Loosely correlated
-1.90%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with KRYS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-1.90%
KRYS - ORMP
48%
Loosely correlated
+0.79%
ALDX - ORMP
45%
Loosely correlated
+5.54%
BPMC - ORMP
44%
Loosely correlated
+0.36%
BTAI - ORMP
44%
Loosely correlated
+9.24%
INO - ORMP
44%
Loosely correlated
+1.25%
More